A Pilot Study of Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapse of Acute Lymphoblastic Leukemia
Phase of Trial: Phase I
Latest Information Update: 13 Aug 2017
At a glance
- Drugs Vincristine (Primary) ; Asparaginase; Dexamethasone; Mitoxantrone
- Indications Lymphoid leukaemia
- Focus Adverse reactions
- 11 May 2017 Planned End Date changed from 1 Mar 2019 to 1 May 2021.
- 11 May 2017 Planned primary completion date changed from 1 Mar 2018 to 31 Aug 2020.
- 13 Sep 2016 New trial record